Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...

Medical specialists often order a multiparametric MRI (mpMRI) following elevated PSA levels to determine if biopsies are ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

Cubs legend and Baseball Hall of Fame member Ryne Sandberg provided an update on health Wednesday morning in a statement ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Dermot Murnaghan has said he ‘fell through the gaps’ before getting his cancer diagnosis. The former Sky News presenter, 67, ...

After he was diagnosed with stage four prostate cancer, Dermot Murnaghan feels like he “fell through the gaps” the regular tests he was having didn't include one for PSA (prostate-specific antigen).